Hera Biotech
San Antonio, US · Founded 2020 · Delaware corporation · 3 known investors
Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
Founders & leadership
Hera Biotech was founded in 2020 by Somer Baburek.
SB
Somer BaburekinCo-Founder, CEO, President
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 3 of 4 rounds · 2020–2025
▶$796.3KraisedSep 2025 · 8 investors · BiotechnologyRule 506(b)
▶$796.3KraisedSep 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somer BaburekExecutive Officer, Director
- Paul CastellaDirector
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Offering amount
- $5M
- Amount sold
- $796.3K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MofferedAug 2024 · BiotechnologyRule 506(b)
▶$6MofferedAug 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaDirector
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Offering amount
- $6M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$260KraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$260KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Paul CastellaExecutive Officer, Director
- Somer BaburekExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $260K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$853.5KraisedFeb 2022 · 19 investors · BiotechnologyRule 506(b)
▶$853.5KraisedFeb 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $853.5K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Hera Health Solutions17 shared keywordsHera Health Solutions is a biotechnology company that develops a proprietary nanotechnology platform to reformulate existing pharmaceutical compounds into more effective and longer-acting therapies. The platform enables rapid optimization of drugs with improved release profiles, reduced toxicity, and scalable manufacturing.
Hera Women's Health14 shared keywordsHera Women's Health operates a physician-led network that provides affiliated OB/GYN practices with shared clinical infrastructure, including maternal-fetal medicine consultation, centralized scheduling, credentialing, and administrative support, while letting each practice keep its own brand and patients. It serves women's health and maternity care practices across Nevada and Arizona, with access to a birth center and Level III NICU at Sunrise Hospital.
Hera11 shared keywordsHello Hera provides senior care coordination services delivered by human "Heroes" supported by AI, handling insurance, appointments, medication management, and other non-clinical care tasks for families with aging parents. The service is covered by Medicare, targeting families managing complex senior healthcare needs.
Hera BioLabs8 shared keywordsHera BioLabs, which has been acquired by Demeetra, developed transposase-based technologies now used by Demeetra to advance Super piggyBac transposase and the CleanCut CHO Platform for cell line development. The work centers on genetic engineering tools for biotech research and development.
Companies competing with Hera Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Hera Biotech do?
- Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
- Who founded Hera Biotech?
- Hera Biotech was founded by Somer Baburek in 2020.
- Who are Hera Biotech's investors?
- Hera Biotech's investors include Coyote Ventures, Portfolia, VentureDNA.
- How much funding has Hera Biotech raised?
- Hera Biotech has disclosed $1.9M raised across 3 of its 4 known rounds.
- Where is Hera Biotech headquartered?
- Hera Biotech is headquartered in San Antonio, US.